ZEUS System vs ASSURE Wearable ECG

When choosing between the ZEUS System by iRhythm Technologies and Kestra Medical Technologies’ ASSURE Wearable ECG, physicians should consider their primary focus for cardiac monitoring. Both are FDA-cleared, HIPAA-compliant AI tools for continuous ECG monitoring, but they cater to slightly different needs.

The ZEUS System excels in long-term continuous cardiac monitoring, specifically for detecting and characterizing arrhythmias like Atrial Fibrillation over periods up to 14 days. Its cloud-based analytics and integration with Zio monitors make it suitable for practices prioritizing comprehensive arrhythmia detection and preliminary report generation. Physicians in cardiology, family medicine, or internal medicine seeking a robust system for extended diagnostic monitoring of both symptomatic and asymptomatic events may find ZEUS more aligned with their needs.

Conversely, the ASSURE Wearable ECG focuses on continuous heart rate monitoring and data collection for at-risk cardiac patients, emphasizing patient comfort and data quality through its SensorFit Garment and Adaptive Patient Intelligence for motion artifact filtering. While also offering alert-based notifications and physiologic trend data, its key practical difference lies in its integrated approach within Kestra’s digital healthcare platform, potentially offering a more streamlined experience for managing a specific cohort of at-risk patients. Cardiologists looking for an intuitive wearable solution with advanced artifact filtering for continuous heart rate monitoring and data collection in a targeted patient population might prefer the ASSURE Wearable ECG.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist